Eva Rossmann

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

N/A

0Author DataRank · unranked

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Predictive biomarkers for PD-1/PD-L1 checkpoint inhibitor response in NSCLC: an analysis of clinical trial and real-world data”.

Predictive biomarkers for PD-1/PD-L1 checkpoint inhibitor response in NSCLC: an analysis of clinical trial and real-world data

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-006464

N/A

0.553DataRank · unranked

39 citations

David Dejardin, Eva Rossmann, Jehad Charo, WeiQing Venus So

Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid Tumors

Cancer Research Communications(2025)10.1158/2767-9764.crc-24-0638

N/A

0.425DataRank · unranked

16 citations

Michael Ong, María E. Rodríguez-Ruiz, Jean-Pascal Machiels, Miguel F. Sanmamed, Vladimir Galvao +23 more